Caritis SN, Sharma S, Venkataramanan R, et al: Pharmacology and placental transport of 17 -hydroxyprogesterone caproate in singleton gestation. Am ] Obstet GynecoIt207(5):398.e1, 2012
Caritis SN, Venkataramanan R, Thon E, et al: Relationship berween 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth. Am] Obstet GynecoI210(2):128.e1, 2014
Carlan S], O'Brien WF, Parsons MT, et al: Preterm premature rupture of membranes: a randomized study of home versus hospital management. Obstet GynecoIt81:61, 1993
Carroll SG, Blott M, Nicolaides KH: Preterm prelabor amniorrhexis: outcome of live births. Obstet Gynecol 86: 18, 1995
Carroll SG, Papaionnou S, Ntumazah IL, et al: Lower genital tract swabs in the prediction of intrauterine infection in preterm prelabour rupture of the membranes. B]OG 103:54, 1996
Casanueva E, Ripoll C, Meza-Camacho C, et al: Possible interplay berween vitamin C deficiency and prolactin in pregnant women with premature rupture of membranes: facts and hypothesis. Med Hypotheses 64:241, 2005
Casey ML, Cox SM, Word A, et al: Cyrokines and infection-induced preterm labour. Reprod Fertil Devel 2:499, 1990
Casey ML, MacDonald PC: Transforming growth factor-beta inhibits progesterone-induced enkephalinase expression in human endometrial stromal cells. ] Clin Endocrinol Metab 81 :4022, 1996
Chat], Bartos A, Egashira M, et al: Combinatory approaches prevent preterm birth profoundly exacerbated by gene-environment interactions. ] Clin Invest 123(9):4063, 2013
Chaim W, Mazor M: Intraamniotic infection with fusobacteria. Arch Gynecol Obstet 251:1,t1992
Challis ]R, Sloboda OM, Alfaidy N, et al: Prostaglandins and mechanisms of preterm birth. Reproduction 124: 1, 2002
Chao TT, Bloom SL, Mitchell ]S, et al: he diagnosis and natural history of false preterm labor. Obstet Gynecol 118(6):1301,t2011
Chuang TH, Ulevitch R]: Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8, and hTLR9. Eur Cyrokine Nerw 11:372,t2000
Cnattingius S, Villamor E, Johansson S, et al: Maternal obesity and risk of preterm delivery.t]AMA 309(22):2362, 2013
Cohen A W, Copel ]A, Macones GA, et al: Unjustiied increase in cost of care resulting from U.S. Food and Drug Administration approval of Makena (17a-hydroxyprogesterone caproate). Obstet Gynecol 117(6): 1408, 2011
Collaborative Home Uterine Monitoring Study Group: A multicenter randomized controlled trial of home uterine monitoring: active versus sham device. Am] Obstet Gynecol 173: 1170, 1995